MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir ® FlexTouch ®, a disposable prefilled insulin pen containing Levemir ® (insulin detemir).

First Insulin Pen with No Push-Button Extension Now Available Novo Nordisk announced the availability of the Levemir (insulin detemir [rDNA origin] injection) FlexTouch, a new prefilled insulin ...

PLAINSBORO, N.J., Nov. 1, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) has approved the prefilled insulin pens ...

PLAINSBORO, N.J., June 19, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest prefilled insulin delivery device Levemir ® FlexTouch ® ...

The Food and Drug Administration has approved Novo Nordisk’s prefilled insulin pens called the NovoLog ® FlexTouch ® and Levemir ® FlexTouch ®. FlexTouch ® pens’ dosing mechanism ensures the ...

PLAINSBORO, N.J. — Novo Nordisk on Thursday announced the launch of Levemir FlexTouch (insulin detemir [rDNA origin] injection), a prefilled insulin delivery mechanism providing a new way for ...

LONDON/WASHINGTON, July 30 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab decision to stop selling its long-acting insulin Levemir in the United States has left some diabetes patients struggling ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk's prefilled insulin pens NovoLog (insulin aspart [rDNA origin] injection) FlexTouch and Levemir (insulin detemir [rDNA origin] ...

Levemir (insulin detemir) is safe to receive while pregnant or breastfeeding. However, factors such as the form you get or the condition the drug helps treat may determine whether you should receive ...

A meta-analysis of clinical data published today in Diabetologia, the medical journal for the European Association for the Study of Diabetes (EASD), demonstrated that the Novo Nordisk long-acting ...

It's not often that Americans opt for a more difficult option over a simple one. But when it comes to insulin to treat the growing ranks of those with diabetes, U.S. patients are much more likely to ...

The approval was also announced at the 2013 Vascular Conference in Montreal, Quebec.